James E Deerfield Mgmt Iii,... Net Worth

The estimated Net Worth of James E Deerfield Mgmt Iii,... is at least $110 Thousand dollars as of 19 July 2021. James Iii owns over 1,071,428 units of Acutus Medical stock worth over $110,035 and over the last 4 years James sold AFIB stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

James Iii AFIB stock SEC Form 4 insiders trading

James has made over 2 trades of the Acutus Medical stock since 2020, according to the Form 4 filled with the SEC. Most recently James bought 1,071,428 units of AFIB stock worth $14,999,992 on 19 July 2021.

The largest trade James's ever made was buying 1,500,000 units of Acutus Medical stock on 5 August 2020 worth over $27,000,000. On average, James trades about 1,285,714 units every 174 days since 2020. As of 19 July 2021 James still owns at least 3,438,589 units of Acutus Medical stock.

You can see the complete history of James Iii stock trades at the bottom of the page.

Insiders trading at Acutus Medical

Over the last 4 years, insiders at Acutus Medical have traded over $34,800 worth of Acutus Medical stock and bought 5,601,584 units worth $87,402,576 . The most active insiders traders include David P Bonita, James E Deerfield Mgmt Iii,..., and Shahzad Malik. On average, Acutus Medical executives and independent directors trade stock every 67 days with the average trade being worth of $18,117. The most recent stock trade was executed by R Scott Huennekens on 3 June 2022, trading 60,000 units of AFIB stock currently worth $34,800.

What does Acutus Medical do?

Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. The company's product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.

Complete history of James Iii stock trades at Acutus Medical

Acutus Medical executives and stock owners

Acutus Medical executives and other stock owners filed with the SEC include:

• Vincent J. Burgess,
  Pres, CEO & Director
• Gary W. Doherty,
  Sr. VP of Fin.
• R. Scott Huennekens CPA, M.B.A.,
  Exec. Chairman
• Steven P. McQuillan,
  Sr. VP of Regulatory & Clinical Affairs
• Charlie Piscitello,
  Chief People Officer
• Tom Sohn,
  Sr. VP, Gen. Counsel & Sec.
• Dr. Derrick Chou Ph.D.,
  Chief Technology Officer
• Dr. Graydon E. Beatty,
  Chief Technology Officer
• Richard M. Kimes,
  Sr. VP of Operations
• David Harrison Roman,
  Sr. VP & CFO
• John F Sheridan,
  Director
• Shahzad Malik,
  Director
• James F. Hinrichs,
  Director
• Tom Sohn,
  SVP, Gen. Counsel & Secretary
• R Scott Huennekens,
  Director
• Kevin Mathews,
  SVP, Commercial
• David Roman,
  President & CEO
• Charlie Piscitello,
  SVP, Chief People Officer
• James E Deerfield Mgmt L.P....,
  
• Gary W. Doherty,
  Chief Financial Officer
• John Barnickel,
  Chief Commercial Officer
• Vincent J Burgess,
  Chief Executive Officer
• David P Bonita,
  Director
• James E Deerfield Mgmt Iii,...,
  
• Advisors Llc Orbi Med Capit...,
  
• James Edeerfield Management...,
  
• Shaden Marzouk,
  Director
• Daniella Cramp,
  Director
• Steven Mc Quillan,
  SVP, Clinical Affairs & QA
• Niamh Louise Pellegrini,
  Director
• Jason K Garland,
  Director
• Takeo Mukai,
  CFO